Adverse events following the administration of hepatitis B vaccines.
Bentsi-Enchill
A
A
University of Ottawa.
D002170:Canada; D003430:Cross-Sectional Studies; D006509:Hepatitis B / Q000517:prevention & control*; D017325:Hepatitis B Vaccines / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D015994:Incidence; D011358:Product Surveillance, Postmarketing; D012307:Risk Factors
D017325:Hepatitis B Vaccines